MiMedx Concludes Enrollment for Phase 2B Study of Osteoarthritis (OA) of the Knee
September 21, 2020 08:30 ET
|
MiMedx Group, Inc
Research Advances Understanding of Amniotic Tissue as Potential Unique Treatment for Painful Chronic Condition that Affects 242 Million People Globally MARIETTA, Ga., Sept. 21, 2020 (GLOBE...
MiMedx Announces Preliminary Third Quarter 2020 Net Sales
September 21, 2020 06:15 ET
|
MiMedx Group, Inc
Third Quarter 2020 Net Sales Expected to be Between $61 Million - $64 Million Latest Corporate Presentation Filed with SEC and Posted to IR Website 2020 Annual Meeting of Shareholders to be Held on...
MiMedx Concludes Enrollment for Phase 3 Plantar Fasciitis Trial
September 17, 2020 11:00 ET
|
MiMedx Group, Inc
Research in Plantar Fasciitis Advances Understanding of Amniotic Tissue as Potential Treatment for Chronic Musculoskeletal Pain and Function Disorders MARIETTA, Ga., Sept. 17, 2020 (GLOBE NEWSWIRE)...
MiMedx Launches EpiCord Expandable Placental Allograft as Addition to Market Leading Portfolio
September 14, 2020 08:00 ET
|
MiMedx Group, Inc
New Allograft Expands to Twice its Size and Provides a Protective Structure to Support the Wound Healing Cascade MARIETTA, Ga., Sept. 14, 2020 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (OTC PINK:...